JPMORGAN CHASE & CO - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 33 filers reported holding SATSUMA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$195,000
+27.5%
46,998
+116.5%
0.00%
Q2 2021$153,000
-67.2%
21,707
-72.5%
0.00%
Q1 2021$467,000
+8.9%
79,052
-15.0%
0.00%
Q4 2020$429,000
+3200.0%
92,953
+2613.2%
0.00%
Q3 2020$13,000
-97.3%
3,426
-79.7%
0.00%
Q2 2020$486,000
+42.5%
16,890
+6.3%
0.00%
Q1 2020$341,000
+1117.9%
15,887
+1001.7%
0.00%
Q4 2019$28,0001,4420.00%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 3,118,761$14,533,0003.83%
Ghost Tree Capital, LLC 904,225$4,214,0001.23%
RA Capital Management 5,914,252$27,560,0000.38%
Vivo Capital, LLC 1,232,394$5,743,0000.26%
Nan Fung Group Holdings Ltd 142,900$666,0000.21%
Ikarian Capital, LLC 629,384$2,934,0000.21%
NEA Management Company, LLC 3,142,958$14,646,0000.17%
SAMLYN CAPITAL, LLC 1,716,067$7,998,0000.11%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$8,788,0000.09%
GSA CAPITAL PARTNERS LLP 90,665$422,0000.04%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders